← Human Trials & Peer-Reviewed Studies
Effects of zinc, magnesium, and chromium supplementation on cardiometabolic risk in adults with metabolic syndrome: A double-blind, placebo-controlled randomised trial.
Plain-language guide to PMID 29773176 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 32 adults.
Key Facts
- PMID
- 29773176
- Journal
- Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Kim HN et al. (4 authors)
- DOI
- 10.1016/j.jtemb.2018.03.022
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
The activities of zinc, magnesium and chromium have a potential association with MetS; therefore, the researchers investigated the effects of zinc, magnesium and chromium supplements on metabolic risk factors in adults with MetS.
The primary endpoint was the change in the MetS components, including serum glucose, triglyceride and high-density lipoprotein cholesterol levels, blood pressure and waist circumference.
Who Took Part
According to the abstract, 32 adults were involved.
By PubMed's age tags, the people studied were young adults, adults, middle-aged adults and older adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
The adults were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Blinding on both sides kept the adults and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
What Was Measured
The primary endpoint was the change in the MetS components, including serum glucose, triglyceride and high-density lipoprotein cholesterol levels, blood pressure and waist circumference.
Topics PubMed links to this paper include Chromium, Dietary Supplements, Magnesium, Metabolic Syndrome, Risk Factors and Zinc.
Author keywords: Inflammation and Insulin resistance.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 32 adults.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2018 (Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)), a journal based in Germany.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.